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Abstract.  Human umbilical vein endothelial cells 
(ECs) have been shown to attach to a ~substrattun  of 
fibrinogen (fg).  Later,  ECs undergo spreading,  organi- 
zation of thick microfilament bundles of the stress 
fiber type, and formation of focal contacts (adhesion 
plaques) that correspond to accumulation of. vinculin 
at the cytoplasmic aspect of the ventral membrane. 
The rate of attachment to fg and the type of spreading 
is virtually identical to that obtained on substrata 
coated with fibronectin (FN).  Antibodies to fg, but not 
to FN, prevent EC adhesion to fg; conversely, antibod- 
ies to FN, but not to fg, prevent adhesion of ECs to a 
FN-coated substratum.  The removal of residual FN 
contamination from fg preparations by means of 
DEAE-cellulose chromatography does not result in any 
difference in EC adhesion on fg. Moreover, pretreat- 
merit  of cells with inhibitors of synthesis and release 
of proteins does not impair their adhesion capacity on 
an fg-coated substratum.  In contrast, human arterial 
smooth muscle cells do not adhere and spread on fg 
substrata but do so on FN. The synthetic peptides 
(GIy-Arg-Gly-Asp[GRGD] and Gly-Arg-Gly-Asp-Ser- 
Pro[GRGDSP]) containing the tripeptide Arg-Gly-Asp 
(RGD), originally found to be responsible for the cell 
binding activity of FN, have been found to inhibit EC 
spreading and the redistribution  of their cytoskeleton, 
including the formation of stress fibers and the local- 
ization of vinculin either on fg or on FN.  Conversely, 
the synthetic peptide Arg-Gly-Gly (RGG) was com- 
pletely uneffective in inhibiting the adhesion and the 
sequence of events leading to spreading and cytoskele- 
tal organization.  These results indicate that ECs, but 
not smooth muscle cells, specifically adhere and 
spread on an fg substratum and this occurs by recogni- 
tion mechanisms similar to those reported for FN. 
NDOTHELIAL cells  (ECs) 1 provide the vascular sys- 
tem with a renewable nonthrombogenic  surface. 
Factors that  contribute to the adhesion, motility, 
and growth  of ECs are important mediators for the main- 
tenance of vascular integrity.  Many authors (20, 32, 43, 51) 
have  shown  that  the  EC  extracellular  matrix  is  able  to 
influence  several aspects of cellular behavior,  including  at- 
tachment,  spreading,  and migration,  and may in part initiate 
and  control  vascular  response  in  growth,  differentiation, 
wound repair,  and neoplasia. 
The basement membrane of ECs is composed of numerous 
macromolecules such as collagen(s),  fibronectin (FN), lami- 
nin, and glycosaminoglycans  (24). Besides these molecules, 
the other substratum that ECs might be expected to interact 
with is fibrinogen  (fg) and/or fibrin.  At sites of vascular in- 
jury fg/fibrin  tend to accumulate on the surface of the ex- 
posed subendothelium (4, 44) and might constitute a substra- 
tum over which ECs can attach,  spread, and proliferate. 
1. Abbreviation~ used in this paper: ECs, human umbilical vein endothelial 
cells; fg, fibrinogen; FN, fibronectin; IRM, interference reflection micros- 
copy; M199, medium 199; R-PHD,  rhodamine-labeled phaUoidin;  SMCs, 
human arterial smooth muscle cells; VN, vitronectin. 
It has been shown in vitro and in vivo that ECs can migrate 
and proliferate into a fibrin clot and that fg and its derivatives 
may greatly influence EC functions (7, 9, 28, 37, 42, 47). Re- 
cently we have shown that native fg specifically binds to ECs 
and induces their migration  (8). 
The microfilamentous  cytoskeleton of ECs is organized  in 
thick bundles (stress fibers) that may be visualized both in 
vitro and in situ (13, 41, 49), and that have been postulated 
to be contractile (for review see reference 22). The distribu- 
tion of stress fibers in situ seems to be influenced by a num- 
ber of different factors (49), including hypertension (13), and 
is particularly prominent during regeneration  of the injured 
vessel wall (14, 26). Moreover,  EC stress fibers have been 
shown  to attach  to the  cytoplasmic  aspect of the plasma 
membrane in situ at structures  resembling typical adhesion 
plaques  and  to  correspond to  fibrillar  bundles  of matrix 
molecules (26).  The organization  of such attachment  sites 
may be particularly relevant in the process of re-endothelial- 
ization of the intimal  layer (26). 
In this report we show that substratum-bound fg, like to 
FN, is able to promote in vitro EC adhesion, spreading,  or- 
ganization of thick microfilament  bundles, and formation of 
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Figure 1. Time course of EC attachment to FN- (open circle),  fg- 
(solid circle),  or BSA- (open triangle) coated glass. The coverslips 
were coated with 10 Ixg/ml FN, 250 p,g/ml fg,  1 mg/ml BSA before 
the assay.  [3H]Thymidine-labeled  cells were seeded  onto different 
substrata.  After the indicated periods  of incubation the cells were 
washed  twice  with  PBS  and  the cells bound  to the substrata ex- 
tracted and counted.  The values are mean  +  SEM of three experi- 
ments performed  on three separate cell cultures. 
focal contacts (adhesion plaques), including local assembly 
of vinculin molecules. This chain of phenomena is prevented 
by the presence in the incubation medium of a peptide con- 
raining the sequence RGD, which has been shown to be part 
of the cell-binding domain of several matrix molecules (25, 
38) and also of fg (15, 23, 40). In contrast, human arterial 
smooth muscle cells (SMCs) fail to adhere and organize their 
microfilaments on fg substrata. 
The findings reported in this paper may be relevant for the 
mechanism of repair of vascular lesions. 
Materials and Methods 
Ce//s 
ECs from human umbilical cords were obtained and cultured as described 
previously (1). The cells were grown to confluence on plastic flasks (Falcon 
Labware,  Oxnard,  CA) in medium  199  (M199)  supplemented with 20% 
FCS.  The cells were cultured at 37"C in a  water-saturated atmosphere of 
95% air-5% COz and fed three times a week. The experiments reported in 
this paper were carried out with ECs at the first passage in vitro. ECs were 
characterized by indirect immunnfluorescence using rabbit anti-human fac- 
tor VIII antigen (Behringwerke AG,  Marburg,  Federal Republic of Ger- 
many) (1). SMCs were kindly donated by Dr. G. Gabbiani (University of 
Geneva, School of Medicine, Geneva, Switzerland). The cells were grown 
in Dulbecco's modified minimal essential medium supplemented with 10 % 
fetal calf serum and cultured as described for ECs. All culture reagents were 
from Gibea Laboratories (Paisley, Scotland). 
Purification of  FN, fg, and  fg Derivatives 
Human plasma FN was purified from freshly drawn citrated blood plasma 
by affinity chromatography on gelatin-Sepharose (10). 
Human fg was purified according to described procedures (29). Poly- 
acrylamide gel  electrophoresis  analysis  (30)  of the purified  material  in 
the presence of SDS and reducing agents demonstrated intact it-, ~, and 
T-chains. Ptasminogen, factors II, XIII, yon Willebrand factor, and fibrin 
monomer could  not be demonstrated  in any  preparation by established 
criteria (8). Contaminating FN was lowered by affinity chromatography on 
gelatin-Sepharose to 5 ng/mg as evaluated by solid-phase radioimmunoassay 
(10). To eliminate contaminating FN,  fg was further chromatographed on 
DEAE-Sephacel colunms (2.5  x  40 cm) after dialysis against the starting 
buffer (U). A linear ionic strength and pH gradient was applied with a gra- 
dient maker (LKB Instruments, Inc., Bromma,  Sweden) using a  starting 
buffer of 0.1M M  Tris, pH 8.5,  and a final buffer ofO.1 M Tris, pH 5.5,  + 
CaCI2 0.1  M.  T~  distinct protein peaks were  resolved (peak I  and II). 
The pooled fractions were dialyzed against NaC1 0.5 M, Tris HC1 0.05 M, 
pH 7.6. 
SDS PAGE according to Laemmli (30) of the reduced starting material 
showed a-chain heterogeneity, intact 13- and T-chain, and a band (215,000 
mol wt) representing the polypeptide chains of FN. The electrophoretic pat- 
tern of peak I was similar to that of the starting material, except that there 
were no bands in the position corresponding to FN, while peak II showed 
a large band corresponding to FN. Each peak was tested for FN concentra- 
tion by solid-phase radioimmunoassay (10). FN was undetectable in peak 
I  (<1 ng/mg fg) and was  17 ng/mg fg in peak II. 
Synthetic Peptides 
Peptides  (GRGD,  GRGDSP,  RGG) were synthesized at Sanofi Research 
(Montpellier, France) by solid-phase synthesis. The purity of these peptides 
was assessed by high performance liquid chromatography.  Hydrolysates 
(24 tl) of the peptides were subjected to amino acid analysis on an automated 
amino acid analyzer. The peptides were more than 90%  homogeneous. 
Antibodies 
Rabbit anti-human plasma fg or FN IgGs were prepared as described (34). 
To ensure specificity, the antisera to fg were adsorbed with plasma from 
an afibrinogenemic patient, and the antisera to FN with plasma was FN- 
deprived by affinity chromatography on gelatin-Sepharose. The IgG frac- 
tions were isolated from the antisera to fg and hydrolyzed with papain. The 
Fab fragments were immunochemically purified by affinity chromatography 
on fg-Sepharose. The specificity and affinity of these Fab fragments have 
already been detailed. Typically, the preparation contains Fabs directed to 
major structural domains of the native molecule, namely D  and E  (34). 
Sephadex G150 chromatography and SDS PAGE verified the absence of non- 
hydrolyzed IgGs and Fc fragments in the Fab preparations. Nonimmune Fab 
fragments were  isolated by carboxymethyl-eellulose chromatography  of 
papain digest of rabbit IgG. The antibodies were checked by immunodiffu- 
sion for the lack of cross-reactivity against the alternative antigen, e.g., anti- 
FN activity in the anti-fg antibodies and vice versa. The vitronectin (VN) 
antibody raised in the rabbit was obtained from Behringwerke.  The anti- 
body was tested for its ability to inhibit EC adhesion to human purified VN 
(Behringwerke). EC adhesion to VN-coated (30 ~tg/ml) glass was measured 
with the same procedure used for fg- or FN-coated substrata described be- 
low in details. The antibody was then used at a concentration able to inhibit 
cell adhesion to VN substrata by 70  ±  2%.  Polyclonal antibody raised 
against platelet glycoprotein (GP) Hb-IIIa (R343) was a kind gift of Dr. E. 
Plow and M. H. Ginsberg (Research Institute of Scripps Clinic, La Jolla, 
CA). This antibody has been shown to precipitate GP Hb-ma-related anti- 
gens in EC, with a mobility similar to platelet GP IIb-llIa by polyacrylamide 
gel analysis (39). 
Preparation and Coating of  Glass Coverslips 
Glass coverslips (10 mm in diameter) were cleaned by sonication for 10 rain, 
then immersed in ethanol/ether (1:1 vol/vol) for 2 h and dried before placing 
in multiwell tissue culture plates (Falcon Labware).  The coverslips were 
coated either with 0.3 ml FN, fg, DEAE-Sephacel elution peaks I or II at 
the required concentrations, or with 0.1%  BSA in PBS containing Ca  ++- 
Mg  +÷, pH 7.4, for 2 h at 37°C. Residual protein-binding sites were blocked 
by further incubation (30 min, 37°C) with 0.2%  BSA in PBS containing 
divalent ions. In some experiments, gelatin (type l]I; Sigma Chemical Co., 
St. Louis, MO) was used at 1% concentration in 0.3 nd water and incubated 
with the coverslips overnight at 4°C.  Coverslips were washed twice with 
PBS before using for experiments. 
To evaluate the actual amount of coverslip-bound protein, fg was trace- 
labeled with carrier-free 125I by the modified chloramine T  method previ- 
ously described  (35).  Bound radioactivity was measured by scintillation 
spectrometry. 
Adhesion and Spreading  Assays 
ECs grown in 25-cm  ~ flasks (~1  x  106 cells/flask) were incubated in 3 ml 
M199 containing 10 ~tCi/ml of [3H]thymidine (specific activity 5 Ci/mmol; 
Amersham International, Amersham,  England) for 24 h.  The cells were 
then washed with 5 ml PBS and detached by brief exposure (1-2 rain) to 
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Figure 2. EC attachment (solid circle) to fg-coated coverslips as a 
function  of fg concentration. Coverslips were incubated  with differ- 
ent concentrations of fg for 2 h at 37°C, then washed twice with 
PBS.  [3H]Thymidine-labeled  ECs  were  seeded  onto  fg-coated 
glass. After 2 h incubation, cells were washed twice with PBS and 
substratum-bound  cells extracted and counted. The values are mean 
5: SEM of three experiments performed on three separate cell cul- 
tures.  Fg concentration on the coverslips (open circle) was evalu- 
ated by coating the glass with [~I]fg as described in Materials and 
Methods.  The values are means +  SEM of four separate  assays. 
a prewarmed 0.25 % trypsin plus 0.02 % EDTA solution in PBS. The trypsin 
action was stopped by adding 10 ml of M199 containing 20% FCS. The cells 
were immediately spun at 1,200 g and resuspended in M199 without serum 
at a concentration of 80-100,000  cells/mi and 1 ml of cell suspension was 
seeded in each well. After 2 h incubation at 37°C, nonadherent cells were 
washed away by rinsing twice with PBS and adherent cells were sohibflized 
by overnight incubation in 0.3 ml Soluene-350 (Packard Instrument Co., 
Downers Grove, IL) and counted by liquid phase scintillation spectrometry. 
In some experiments, adherent cells were characterized as ECs by means 
of indirect immunofluorescence using factor VIII antigen antibodies (see 
above). In some experiments, in order to prevent de novo protein synthesis, 
20 gM cycloheximide (Sigma Chemical Co.) was added to cells 60 min be- 
fore detachment from flasks and kept in all buffers used, even during the 
adhesion assay.  In a  further set of experiments, 1 gM monensin (Sigma 
Chemical Co.) was also added to buffers before and during the adhesion as- 
say to prevent the secretion of adhesive factors. 
The direct involvement of different molecules in promoting the adhesion 
of ECs was also tested by exposing substrata and cells to specific antibodies. 
Anti-FN, anti-VN, anti-fg Fab fragments, and preimmune rabbit IgG Fab 
fragments were added to coated coverslips for 1 h at 37°C before beginning 
the adhesion assay. In the same experiments the antibodies were also added 
to cell suspensions for 30 min before seeding cells into the culture wells and 
kept during the adhesion assay. In some experiments the effects of synthetic 
peptides were evaluated by means of a spreading assay. This was done by 
counting rhodamine-labeled phalloidin (R-PHD)-stained cells (see next 
paragraph) and scoring as spread ECs those in which well-defined microfila- 
ment bundles of the stress fibers type were observed as the percentage of 
total adherent cells. 
Fluorescence Microscopy 
Coverslip-attached cells were fixed in 3%  formaldehyde in PBS, pH 7.6, 
containing 2 % sucrose for 5 min at room temperature. After thorough rins- 
ing in PBS, cells were made permeable to large molecules by soaking cover- 
slips for 5 rain at 0°C in Hepes-Triton X-100 buffer (20 mM Hepes, pH 7.4, 
300 mM sucrose, 50 mM NaCI, 3 mM MgCI2,  and 0.5 % Triton X-100). 
This fixation and permeabilization procedure has been shown to yield op- 
timal preservation of cells for adhesion studies (33,  45). 
Fixed and permeabilized cells were stained with 2 ~rg/ml R-PHD (a kind 
gift of Dr. 1". Wieland, Max Planck Institute for Experimental Medicine, 
Heidelberg, Federal Republic of Germany) for 30 min at 370C and mounted 
in 50% PBS-glycerol. R-PHD has been shown to bind firmly to F-actin (50). 
In some experiments coverslip-attached cells, fixed and permeabilized as 
above,  were simultaneously stained for F-actin with fluorescein-labeled 
phalloidin and with a mouse monoclonal antibody against vinculin (code 
Table L EC Attachment to  fg and FN Substrata 
and Effect of  Antibodies 
Substrata  Cells/cm: 
BSA  9,100  5-  1,400 
Fg  16,800  5- 500 
Fg-etFN  18,200  5-  1,600 
Fg-afg  1,900  5-  100 
Fg-ctVN  21,100  5- 2,900 
FN  34,600  5- 4,000 
FN-ctFN  12,000  +  3,400 
FN-ctfg  35,900  5- 700 
Fg DEAE Sephacel-fraction I  17,900  +  2,000 
Fg DEAE Sephacel-fraction II  16,500  ±  1,800 
Fg DEAE Sephacel-fraction I  and FN  17,000  5- 700 
ECs were seeded onto coverslips coated with BSA (1,000  I~g/rnl), fg (250 
Ixg/ml), FN (10 Irg/rnl), fg-DEAE-Sephacel  fractions  I and II (250 Ixg/ml) or 
fg-DEAE-Sephacel  fraction I added with 0.5 ltg/ml FN. The antibodies against 
fg, FN, or VN were added to protein-coated coverslips for 1 h before the assay 
and were maintained during the assay. The values are expressed as number of 
cells attached  in respect to the total  number of cells seeded.  The values are 
means +  SEM of three experiments performed on three separate cell cultures. 
6501, clone VIN-U-5; Bio-Yeda, Rehovot, Israel). The vinculin localization 
was  revealed with a  rhodamine-tagged rabbit  anti-mouse IgG  (DAKO- 
PATTS, Copenhagen, Denmark). 
Observations were carried out in a Leitz Diavert microscope equipped 
for epifluorescence and interference reflection microscopy (IRM). Fluores- 
cence images were recorded on Kodak TriX films exposed at 1000 ISO and 
developed in Nucleol BF 200 (Chimifoto Ornano, Milan, Italy); parallel 
IRM  patterns were  recorded on  Ortho  25  films developed in  Neuton 
NEUTRAL (Agfa, Gevaert, Milan, Italy). 
Results 
Attachment of  ECs to fg 
Suspensions of ECs were seeded on glass coverslips coated 
with  different proteins  (see  Materials  and  Methods).  As 
shown in Fig.  1, more than 30,000/cm 2 cells attached within 
2 h to FN, ,,o17,000 to fg-coated glass coverslips, and fewer 
(%000) adhered to a BSA substratum.  The endothelial nature 
of adherent  ceils was established by their positivity for the 
presence of factor VIII antigen. After 2-h adhesion tests, the 
nonadherent  cells showed more than 95 % viability by Try- 
pan blue exclusion test. 
The kinetics of the process appeared to be very similar for 
both FN and fg, since it reached a plateau in ~2 h. 
The degree of EC adhesion was also dependent on the con- 
centration of fg and reached a plateau at 100-500 l~g/ml (Fig. 
2), Then the conditions routinely used for assays of EC adhe- 
sion to fg included coverslip coating with 250 gg/ml fg and 
2  h incubation.  Using  [12sI]fg, we evaluated  the amount of 
the protein bound to the glass after the coating procedure 
(Fig. 2). The curve of fg binding to the coverslips was paral- 
lel  to  that  of the  adherent  cells.  The  amount  of  [usI]fg 
bound to the glass did not significantly change between 100 
and  500  lxg/ml;  a  moderate  increase was observed using 
1,000  gg/ml.  We routinely adopted an FN concentration of 
10 ~tg/ml, since the number of adherent cells did not vary be- 
tween 10 and 250 Ixg/ml (data not shown). 
Role of  Contarainating FN on EC Adhesion to fg 
To  investigate  whether EC  adhesion to  fg was in fact  at- 
tributable to this molecule and not to FN contaminating the 
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Figure 3. Concentration-dependent  inhibition of EC adhesion (A) 
and spreading (B and C) to FN or fg by synthetic tmptides. For 
adhesion  experiments  [3H]thymidine-labeled  ECs  were  seeded 
onto FN (10 I~g/ml, solid circle), fg (250 I~g/ml, open circle) in the 
presence of increasing concentrations of peptides. The values, ex- 
pressed as percentage of cells attached to different substrata in the 
absence of peptides, are means of three separate experiments per- 
formed on three distinct cell cultures. SEM never exceeded 15 % of 
the mean. The cells attached in the absence of peptides were 38,190 
+  3,100/cm  2 on FN, 27,156 ±  1,930/cm  2 on fg (means ±  SEM of 
triplicate experiments). For spreading experiments cells were fixed 
and stained with R-PHD as described in Materials and Methods. 
The number  of spread ECs  showing well-defined microfilament 
bundles was expressed as percentage of total adherent cells. Values 
are means of three separate experiments. SEM never exceeded 10% 
of the mean. 
preparation,  a  series of experiments was performed using 
different approaches. 
Specific FN antibodies were incubated with fg-coated cov- 
erslips and ECs and left in the culture medium for the dura- 
tion of the experiment. As shown in Table I, no change in 
EC adhesion to fg was observed in these conditions.  How- 
ever, the antibody concentration used was able to reduce EC 
adhesion to FN by *60%. 
The FN concentration  contaminating the fg preparation 
used in these experiments was removed by affinity chroma- 
tography on Sepharose-bound gelatin.  To remove residual 
minimal amounts of contaminating FN, a chromatographic 
fractionation of fg on  DEAE-Sephacel was performed by 
continuous  salt and pH gradient elution as previously de- 
scribed in detail (11). The elution pattern revealed two peaks 
of fg differing for elution properties. 
The FN amount contained in the  two  fractions was <1 
rig/rag fg in fraction I and 17 ng/mg fg in fraction H. When 
the coverslips were coated with either  fraction I  or H  no 
difference in EC adhesion was observed (Table I). Further- 
more, addition of 0.5 ~tg/ml of FN to peak I did not change 
EC adhesion as well. 
To exclude that VN, possibly contaminating the fg prepa- 
ration used, could mediate EC adhesion, a specific VN anti- 
body was tested. As reported in Table I, cell adhesion on fg 
was unaffected. 
Role of  Protein Synthesis and Secretion 
on EC Adhesion to  fg 
To investigate the role of synthesis and secretion of proteins 
in the process of adhesion to fg, ECs were treated with cyclo- 
heximide and monensin. Cycloheximide (20 gM) was added 
to cells 60 min before detachment.  At this concentration, 
protein synthesis was inhibited by 98 % as previously shown 
(45).  Monensin  (1  I~M)  was used  to prevent secretion of 
adhesive factors (46) and was also added to all buffers used 
and to the adhesion medium. 
Treatment of cells with cycloheximide and monensin, ei- 
ther individually or in combination, did not significantly re- 
duce cell adhesion to BSA, fg, or FN (data not shown). 
Effects of  Hirudin and Aprotinin 
on fg-induced EC Adhesion 
To investigate whether thrombin or plasmin might play any 
role in adhesion of ECs to fg, hirudin (10 U/ml) and aprotinin 
(4,000 KIU/ml) were added to the medium during the adhe- 
sion experiment. No effect of these substances was observed 
on EC adhesion to fg, since 16,800 +  400 of cells adhered 
in the absence of inhibitors,  16,950  +  401  in the presence 
of hirudin,  and  1%420 +  901  in the presence of aprotinin 
(means +  SEM of four experiments). The concentrations of 
inhibitors used were able to neutralize •1-10  U/ml thrombin 
and 4,000 U/ml plasmin, respectively. 
Inhibition of  EC Adhesion and Spreading 
by Synthetic Cell Attachment-promoting Peptides 
To find out whether cell adhesion to fg was mediated by the 
same molecular mechanism as to FN, the synthetic peptide 
GRGD, containing the tripeptide RGD, originally found to 
be responsible for the FN cell attachment activity (38), was 
tested on ECs. The RGD sequence is also found at residues 
95-97 and 572-574 of the 611 amino acids of the or-chain of 
fg. As shown in Fig. 3 A, GRGD was able to inhibit EC adhe- 
sion either to fg or to FN. In contrast, GRGD was completely 
uneffective up to 1 mg/ml in inhibiting EC adhesion to gelatin 
(30,412  +  3,200  ceUs/cm  2 in  the  absence  and  31,500  + 
1,200 ceUs/cm  2 in the presence of the peptide).  When the 
peptide RGG was used to test the structural specificity of the 
GRGD effect, no inhibition of EC adhesion was observed, 
both on FN and fg substrata. 
Fig. 3, B and C, reports the effects of GRGD and GRGDSP 
on EC spreading.  Both peptides had a comparable activity 
in preventing cell spreading on fg and on FN;  a  virtually 
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cases, whereas, by simply considering the adhesion phenom- 
enon, only 50%  inhibition was achieved by GRGD. 
We tested whether an antibody raised against platelet GP 
IIb-ffla inhibited EC spreading on fg. This antibody (R343) 
has been shown (39) to precipitate GP IIb-llla-related anti- 
gen in ECs with a mobility similar to platelet GP IIb-IIIa by 
polyacrylamide gel analysis. While EC adhesion was  in- 
hibited by 33 % (1,712 +  150 vs. 1,329 +  102), cell spreading 
was blocked by the presence of the antibody (94 % of total 
adherent cells spread in the absence, while only 2 % spread 
in the presence of the an.  tibody). 
Spreading and Organization of  Microfilamentous 
Structures of  ECs Plated on fg 
The distribution of the microfilamentous cytoskeleton and 
the localization of vinculin were studied by fluorescence mi- 
croscopy on fixed and permeabilized ECs. F-actin was re- 
vealed  with  fluorochrome-labeled PHD,  a  fungine cyclic 
polypeptide that binds selectively to F-actin (50). Vinculin 
was identified immunologically with a specific monoclonal 
antibody that has been shown to recognize the mammalian 
form (18). In the same cells, the extent of  adhesion was evalu- 
ated by IRM, a technical means that records the distance be- 
tween the adhesion substratum and the cell ventral mem- 
brane (5,  27, 48):  the smaller the distance, the darker the 
signal intensity, black indicating tight adhesion. 
When ECs were plated on BSA-coated glass coverslips 
they remained rounded and only a small proportion partially 
adhered to the substratum. In these conditions, F-actin did 
not assemble in microfilament bundles after 30 rain (Fig. 4 
A); at 2 h after plating only a few cells showed thin microfila- 
ment bundles and none exhibited thick bundles of the stress 
fiber type (Fig. 4 B). No adhesion plaques were apparent by 
IRM (not shown). 
Upon plating on FN- or fg-coated glass coverslips, ECs 
progressively adhered and spread. In a few cells attachment 
was apparent already at 30 min but no obvious microfilament 
bundles of the stress fiber type were visible (Fig. 4, C and 
E). At 2 h (Fig. 4, D and F) spreading of  most cells was com- 
plete  and  a  network of thick microfilament bundles  had 
formed. The microfilamentous cytoskeleton was stable for at 
least 1 d and its pattern was identical to that shown at 2 h 
(not shown). No obvious difference in microfilament distri- 
bution was found in ECs plated either on FN or on fg. 
At 2 h after plating, spreading and cytoskeleton organiza- 
tion (Fig. 4  G) was also complete when coverslips were 
coated with DEAE-Sephacel peak I fraction, which has been 
shown to be devoid of significant FN contamination. This 
rules out the possibility that spreading activity may be at- 
tributed  to  contaminant  FN.  Conversely,  spreading  and 
stress fiber assembly was totally abolished when ECs were 
seeded on peak I-coated coverslips in the presence of GRGD 
(Fig. 4 H). The control peptide RGG by no means impaired 
spreading and cytoskeletal organization (not shown). 
The formation of stress  fibers occurred simultaneously 
with the appearance of vinculin streaks at their endings in 
correspondence with adhesion sites. In fact, cells plated ei- 
ther on fg (Fig. 5, A-C) or on FN (Fig. 5, G--l) showed mul- 
tiple IRM black streaks, which mostly corresponded to the 
endings of stress fibers and distinct arrowhead-shaped vincu- 
lin speckles (e.g., at arrowheads). Again, no obvious differ- 
ence was appreciated in cells spread either on fg or on FN. 
While in the presence of GRGD the formation of tight adhe- 
sion sites was abolished (Fig. 5, D-F). 
Spreading and Organization of  Microfilamentous 
Structures of  SMCs Plated on fg 
The organization of microfilaments has also been studied on 
fixed and permeabilized SMCs seeded on BSA, fg, and FN. 
Fig. 6 shows that on both BSA and fg, in the absence of se- 
rum, most cells were void of organized microfilament bun- 
dles (A and B). In contrast, SMCs seeded on FN showed a 
well-developed array of stress fibers, indicating that the cells 
had undergone full spreading (Fig. 6 C). Of the total adher- 
ent SMCs, 90%  spread on FN while only ~2%  on fg or 
BSA. 
This data indicate that spreading on fg does not occur on 
SMCs, showing that, among cells of the vessel wall, such an 
event is peculiar to ECs. 
Discussion 
The results reported here indicate that ECs adhere to an fg 
substratum and eventually undergo spreading, expression of 
stress fibers, and formation of  adhesion plaques. The activity 
of fg in supporting such phenomena is somehow weaker than 
FN,  since  the total number of adhering ECs was always 
lower.  Qualitatively, however,  the pattern of microfilament 
organization and number and extent of focal adhesion con- 
tacts are closely comparable. This phenomenon is of  particu- 
lar relevance,  since  it provides evidence that the plasma 
membrane has interacted via specific receptors with the ex- 
tracellular matrix (for review see reference 6; see also refer- 
ence 19) and that this interaction has triggered a cascade of 
events leading to the organization of the adhesion plaque 
at which vinculin and other proteins are associated (2,  3, 
16-18, 48). 
Grinnell et al. (21) reported that baby hamster kidney cells 
did not attach to substrata composed of purified fg, but that 
adhesion was supported when plasma FN was covalenfly 
cross-linked to fg. The data reported here do not confirm this 
observation on ECs. 
The ability of fg does not appear to be due to contaminat- 
ing FN or VN, since addition of FN or VN antibodies to the 
culture medium or removal of residual contaminating FN 
from fg preparations by DEAE-Sephacel chromatography 
does  not impair  fg-induced EC  adhesion and  spreading. 
Other possible contaminants, like plasminogen,  factor II, 
XIII, and VIII, yon Willebrand factor, and fibrin monomers 
could not be demonstrated in any preparations by established 
criteria (8) and do not appear, therefore, to play any major 
role in fg-induced EC adhesion. 
ECs have been shown to interact with fibrin (28) and fg 
plasmin-degradation products  (7).  These  molecules  have 
been shown to induce EC contraction and disruption of the 
cell monolayer (7, 28).  Therefore, we tested the possibility 
that thrombin or plasmin, possibly generated in the system, 
might interact with fg or directly with ECs to modulate the 
adhesion process. The results indicate that very high concen- 
trations of hirndin and aprotinin, capable of inhibiting high 
concentrations of thrombin and plasmin, do not virtually 
Dejana et al.  Fibrinogen-induced Endothelial Cell Adhesion  1407 Figure 4.  Distribution of F-actin stained by RopHD in ECs seeded on coverslips coated with BSA (A and B), fg (C and D), FN (E and 
F), and DEAE-Sephacel peak I (G and H). Time after seeding was 30 min (A, C, and E) and 2 h (B, D, F,, G, and H); in H incubation 
was carried out in the presence of 0.6 mg/ml GRGD. No microfilament bundles of the stress fiber type appear 30 min after seeding on 
The Journal of Cell Biology, Volume 104, 1987  1408 Figure 5. Immunofluorescence localization of vinculin (B, E, and H) and IRM patterns  of ECs (C, E  and I) compared with the distribution 
of fluorescein-labeled  phalloidin-stained F-actin (A, D, and G). ECs were allowed to spread for 2 h on fg-coated coverslips in the presence 
(D--F) or in the absence (A-C) of the tetrapeptide  GRGD (0.6 mg/ml) or on FN-coated coverslips  (G--/). The peptide inhibited  spreading 
of ECs on fg as well as the appearance  of vinculin speckles and adhesion plaques (A-C, e.g., arrowheads).  Bar,  5 ~m. 
change the number of cells adhering to fg and thus exclude 
the need for these two enzymes in fg-induced EC adhesion 
and spreading. 
EC attachment to fg might be influenced by de novo syn- 
thesis and release of FN or other adhesive proteins by the 
cells. The data reported in this paper do not support this pos- 
sibility, since cycloheximide and monensin treatment at con- 
centrations able to suppress synthesis and external exposure 
of proteirls did not affect EC adhesion to fg. In addition anti- 
FN antisela were uneffective in reducing EC adhesion to fg 
substrata, thus indicating that membrane-associated FN does 
not mediate EC adhesion to fg. 
BSA, fg, or FN (A, C, and E). 2 h after seeding  microfilament  bundles did not appear in ECs plated on BSA (B) but were abundantly 
assembled in cells plated  on fg, FN, or peak I (D, F,, and G). When ECs were plated  on peak 1-coated coverslips  and incubated in the 
presence of  the tetrapeptide  GRGD for 2 h, spreading and microfilament organization were impaired (H). No obvious difference in microfila- 
ment distribution was found in ECs after spreading, either on fg (D) or on FN (F).  Bars,  5 lxm. 
Dejana et al. Fibrinogen-induced Endothelial Cell Adhesion  1409 Figure 6. Distribution of F-actin after staining with R-PHD in SMCs seeded on coverslips coated with BSA (A), fg (B), or FN (C) 2 
h after seeding. Bar, 5 Bm. 
The structural domain of the fg molecule that takes part 
in EC adhesion remains to be fully characterized. Piersch- 
bacher and Ruoslathi (38)  demonstrated that the ability of 
FN to bind to cells and to promote adhesion can be accounted 
for by the tripeptide RGD located in the cell attachment do- 
main of FN. This sequence is also present in several other 
proteins including fg (38).  These authors showed that pep- 
tides containing the RGD sequence inhibited the attachment 
of  various cell lines to FN and vitronectin, while they did not 
have any effect on cell attachment to collagen (25).  Plow et 
al. (40), Haverstick et al. (23), and Gartner and Bennett (15) 
demonstrated that RGD-containing peptides  inhibited the 
binding of FN and fg to stimulated platelets and thus estab- 
lished a common feature in the interaction of  either molecule 
with  platelets.  In  this  paper  we  show  that  GRGD  and 
GRGDSP block EC spreading and the organization of  micro- 
filaments on fg and FN.  ECs might therefore recognize a 
similar molecular domain of fg and FN as do fibroblasts or 
platelets.  However, while the GRGD sequence is poorly ac- 
tive on platelets (23, 40), ECs appear to equally recognize 
both GRGD and GRGDSP. In the presence of GRGD, a rela- 
tive discrepancy between data of adhesion versus spreading 
has been observed. This peptide, in fact, couM never fully 
inhibit adhesion, while almost complete inhibition of spread- 
ing was achieved. This result points to the idea that a trans- 
membrane cascade of  events leading to cytoskeletal reorgani- 
zation depends upon an RGD recognition mechanism. 
The GRGD effect was evident only when cells were plated 
either on FN or on fg but not on gelatin. Hyman et al. (25) 
reported that RGD-containing peptides did not prevent nor- 
mal rat kidney cell attachment to collagen; the author sug- 
gested that, even if collagen contains many RGD sequences, 
they may not be the recognition sites for cells during the ini- 
tial stage of attachment. 
Several reports (12, 31, 36, 39)  showed that proteins im- 
munologically related to the platelet fg receptor GP IIb-IIIa 
are also present in ECs. In preliminary experiments we ob- 
served that an antibody against the platelet GP complex was 
able to block EC spreading on fg; this suggests that the cell 
binding sites for fg on ECs is immunologically related to 
platelet GP IIb-IIIa. 
In conclusion, the results reported here indicate that ECs 
adhere to fg as they do to FN. The ability of RGD-containing 
peptides in inhibiting cell spreading on either molecule sug- 
gests that, in analogy with platelets, EC interaction on these 
substrata is mediated by the same recognition determinant. 
The relevance of  these observations to the behavior of ECs 
in vivo remains to be established. Fg and fibrin are known 
to interact with subendothelial structures and to accumulate 
at sites of vascular injury (4, 44).  ECs at the periphery of 
the lesion might therefore be expected to come in contact 
with fg and fg dedx;atives. Indeed, the minimal fg concentra- 
tion able to promote EC adhesion and spreading is less than 
one-tenth of  that of  plasmatic fg and might therefore be easily 
reached at sites of vessel injury. 
It has been reported by several  authors that extracellular 
matrix molecules deeply affect  EC spreading, migration, and 
proliferation (32, 51). Fg appears to bind specifically to ECs 
(8), to promote adhesion and organization of  microfilaments, 
and,  in the Boyden chamber  system,  it  seems  to  induce 
migration of these cells. Further investigations are needed to 
establish whether the above fg-induced activities have any 
relevance in the rate at which ECs migrate into a vascular le- 
sion and affect intimal repair. 
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